✦ LIBER ✦

Fluoroquinolones reduce CHD risk in type 2 diabetes

Book ID: 120861934
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2002
Weight: 139 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200213650-00042

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CHD and diabetes—target dyslipidaemia, r

CHD and diabetes—target dyslipidaemia, reduce the risk

✍ D.John Betteridge; Jaakko Tuomilehto 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Ramipril may reduce risk of type 2 diabe

Ramipril may reduce risk of type 2 diabetes

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 139 KB

CHD: a major burden in type 2 diabetes

✍ R. Nesto 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 99 KB

Could pravastatin reduce the risk of typ

Could pravastatin reduce the risk of type 2 diabetes?

✍ Minal Chande 📂 Article 📅 2001 🏛 The Lancet 🌐 English ⚖ 62 KB

Reducing cardiovascular risk in type 2 d

Reducing cardiovascular risk in type 2 diabetes mellitus

✍ David Preiss; Naveed Sattar 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 250 KB

Pharmacological Strategies to Reduce Car

Pharmacological Strategies to Reduce Cardiovascular Risk in Type 2 Diabetes Mellitus

✍ Dr Marcel M. C. Hovens, Jouke T. Tamsma, Edith D. Beishuizen, Menno V. Huisman 📂 Article 📅 2005 🏛 Springer International Publishing AG 🌐 English ⚖ 192 KB